Entrada Therapeutics, Inc. TRDA
4.35 USD -0.29 (-6.25%)
Regular-session close
4.20 -0.15 -3.45%
After hours · Nov 20, 4:36 PM ET
4.32 Day range 4.58
4.35 52-week range 16.03
- YTD
- -57.68%
- 1 year
- -52.56%
Held by funds
62 US ETFs and mutual funds hold TRDA · largest positions
- VTI 0.00% of fund $6.06M
- NJM 0.01% of fund $4.41M
- IWM 0.01% of fund $4.16M
- FSSNX 0.01% of fund $2.28M
- VXF 0.00% of fund $1.80M
- NAJ 0.01% of fund $1.62M
- IWN 0.01% of fund $1.59M
- VTWO 0.01% of fund $1.11M
- IBB 0.01% of fund $1.00M
- FSMAX 0.00% of fund $791.94K
- SCHA 0.00% of fund $741.74K
- DFAS 0.00% of fund $489.05K
- IWC 0.04% of fund $487.32K
- IJE 0.03% of fund $478.71K
- DFMC 0.01% of fund $442.69K
- VHT 0.00% of fund $368.79K
- AVSC 0.01% of fund $367.86K
- FISVX 0.01% of fund $303.59K
- MDSKX 0.00% of fund $264.83K
- GSSC 0.02% of fund $250.32K
Ownership
- Institutions 80.8%
- Insiders 12.8%
- Public and other holders 6.38%
Held by insiders 12.77%
Held by institutions 80.85%
Float held by institutions 92.69%
Institutions 150
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Baker Bros. Advisors, LP | 13.00% | 4,865,819 | 84.96M | Sep 29, 2024 |
| MPM Asset Management, LLC | 11.83% | 4,425,784 | 77.27M | Sep 29, 2024 |
| 5AM Venture Management, LLC | 11.78% | 4,408,379 | 76.97M | Sep 29, 2024 |
| Price (T.Rowe) Associates Inc | 8.15% | 3,049,572 | 53.25M | Sep 29, 2024 |
| Blackrock Inc. | 4.87% | 1,822,835 | 31.83M | Sep 29, 2024 |
| FMR, LLC | 4.66% | 1,743,498 | 30.44M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Price (T.Rowe) New Horizons Fund | 5.19% | 1,942,377 | 33.91M | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 1.81% | 677,414 | 11.83M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.70% | 634,828 | 11.08M | Oct 30, 2024 |
| Price (T.Rowe) New Horizons Trust | 1.20% | 449,109 | 7.84M | Sep 29, 2024 |
| Fidelity Growth Company Fund | 0.96% | 357,801 | 6.25M | Oct 30, 2024 |
| Fidelity Select Portfolios - Biotechnology | 0.83% | 309,169 | 5.40M | Oct 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DOSHI DIPAL | Chief Executive Officer | Sale | Jul 14, 2024 | 334,475 |
| DOWDEN NATHAN J | President | Sale | Sep 25, 2024 | 125,149 |
| KIM PETER S | Director | Conversion of Exercise of derivative security | Jun 2, 2024 | 104,330 |
| KREHER NERISSA C | Officer | Sale | Sep 5, 2023 | 40,037 |
| SETHURAMAN NATARAJAN | Officer | Sale | Dec 2, 2024 | 144,997 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Conversion of Exercise of derivative security | Dec 1, 2024 | 73,849 |
